| 2015 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. | Lei, J; Rudolph, A; Moysich, KB; Rafiq, S; Behrens, S; Goode, EL; Pharoah, PP; Seibold, P; Fasching, PA; Andrulis, IL; Kristensen, VN; Couch, FJ; Hamann, U; Hooning, MJ; Nevanlinna, H; Eilber, U; Bolla, MK; Dennis, J; Wang, Q; Lindblom, A; Mannermaa, A; Lambrechts, D; Garcia-Closas, M; Hall, P; Chenevix-Trench, G; Shah, M; Luben, R; Haeberle, L; Ekici, AB; Beckmann, MW; Knight, JA; Glendon, G; Tchatchou, S; Alnaes, GI; Borresen-Dale, AL; Nord, S; Olson, JE; Hallberg, E; Vachon, C; Torres, D; Ulmer, HU; Rudiger, T; Jager, A; van Deurzen, CH; Tilanus-Linthorst, MM; Muranen, TA; Aittomaki, K; Blomqvist, C; Margolin, S; Kosma, VM; Hartikainen, JM; Kataja, V; Hatse, S; Wildiers, H; Smeets, A; Figueroa, J; Chanock, SJ; Lissowska, J; Li, J; Humphreys, K; Phillips, KA; Linn, S; Cornelissen, S; van den Broek, SA; Kang, D; Choi, JY; Park, SK; Yoo, KY; Hsiung, CN; Wu, PE; Hou, MF; Shen, CY; Teo, SH; Taib, NA; Yip, CH; Ho, GF; Matsuo, K; Ito, H; Iwata, H; Tajima, K; Dunning, AM; Benitez, J; Czene, K; Sucheston, LE; Maishman, T; Tapper, WJ; Eccles, D; Easton, DF; Schmidt, MK; Chang-Claude, J | Breast cancer research : BCR 17, 18 | | | |
